Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 1
1986 2
1987 1
1988 3
1990 2
1991 4
1992 2
1993 3
1994 4
1997 1
1999 3
2000 2
2001 4
2002 5
2003 7
2004 10
2005 7
2006 4
2007 5
2008 6
2009 9
2010 11
2011 13
2012 15
2013 9
2014 5
2015 7
2016 10
2017 5
2018 1
2019 3
2020 3
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells.
Ottinger HD, Müller CR, Goldmann SF, Albert E, Arnold R, Beelen DW, Blasczyk R, Bunjes D, Casper J, Ebell W, Ehninger G, Eiermann T, Einsele H, Fauser A, Ferencik S, Finke J, Hertenstein B, Heyll A, Klingebiel T, Knipper A, Kremens B, Kolb HJ, Kolbe K, Lenartz E, Lindemann M, Müller CA, Mytilineos J, Niederwieser D, Runde V, Sayer H, Schaefer UW, Schmitz N, Schröder S, Schulze-Rath R, Schwerdtfeger R, Siegert W, Thiele B, Zander AR, Grosse-Wilde H. Ottinger HD, et al. Among authors: schwerdtfeger r. Ann Hematol. 2001 Dec;80(12):706-14. doi: 10.1007/s00277-001-0384-9. Epub 2001 Oct 25. Ann Hematol. 2001. PMID: 11797110 Review.
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.
Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, Stadler M, Ayuk F, Kiani A, Schwerdtfeger R, Vogelsang GB, Kobbe G, Gramatzki M, Lawitschka A, Mohty M, Pavletic SZ, Greinix H, Holler E. Wolff D, et al. Among authors: schwerdtfeger r. Biol Blood Marrow Transplant. 2011 Jan;17(1):1-17. doi: 10.1016/j.bbmt.2010.05.011. Epub 2010 May 26. Biol Blood Marrow Transplant. 2011. PMID: 20685255 Free article.
KnowVolution of a Fungal Laccase toward Alkaline pH.
Novoa C, Dhoke GV, Mate DM, Martínez R, Haarmann T, Schreiter M, Eidner J, Schwerdtfeger R, Lorenz P, Davari MD, Jakob F, Schwaneberg U. Novoa C, et al. Among authors: schwerdtfeger r. Chembiochem. 2019 Jun 3;20(11):1458-1466. doi: 10.1002/cbic.201800807. Epub 2019 Apr 15. Chembiochem. 2019. PMID: 30702209
Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation.
Stift J, Baba HA, Huber E, Federmann B, Fischer HP, Schmitt-Graeff A, Baurmann H, Bethge W, Schirmacher P, Wrba F, Greinix H, Fend F, Schwerdtfeger R, Shulman HM, Wolff D, Longerich T; Liver Pathology Group of the German-Austrian-Swiss Working Group on GvHD. Stift J, et al. Among authors: schwerdtfeger r. Virchows Arch. 2014 Feb;464(2):175-90. doi: 10.1007/s00428-013-1528-8. Epub 2014 Jan 3. Virchows Arch. 2014. PMID: 24385287
HLA-E polymorphisms in hematopoietic stem cell transplantation.
Fürst D, Bindja J, Arnold R, Herr W, Schwerdtfeger R, Müller CH, Recker K, Schrezenmeier H, Mytilineos J. Fürst D, et al. Among authors: schwerdtfeger r. Tissue Antigens. 2012 Apr;79(4):287-90. doi: 10.1111/j.1399-0039.2011.01832.x. Epub 2012 Jan 18. Tissue Antigens. 2012. PMID: 22256791
Efficacy of exercise training in SCT patients--who benefits most?
Wiskemann J, Kuehl R, Dreger P, Schwerdtfeger R, Huber G, Ulrich CM, Jaeger D, Bohus M. Wiskemann J, et al. Among authors: schwerdtfeger r. Bone Marrow Transplant. 2014 Mar;49(3):443-8. doi: 10.1038/bmt.2013.194. Epub 2013 Dec 9. Bone Marrow Transplant. 2014. PMID: 24317122 Clinical Trial.
Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission.
Díaz-Beyá M, Labopin M, Maertens J, Aljurf M, Passweg J, Dietrich B, Schouten H, Socié G, Schaap N, Schwerdtfeger R, Volin L, Michallet M, Polge E, Sierra J, Mohty M, Esteve J, Nagler A; Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). Díaz-Beyá M, et al. Among authors: schwerdtfeger r. Br J Haematol. 2020 Jun;189(5):920-925. doi: 10.1111/bjh.16433. Epub 2020 Feb 5. Br J Haematol. 2020. PMID: 32020596 Free article.
High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
Hehlmann R, Voskanyan A, Lauseker M, Pfirrmann M, Kalmanti L, Rinaldetti S, Kohlbrenner K, Haferlach C, Schlegelberger B, Fabarius A, Seifarth W, Spieß B, Wuchter P, Krause S, Kolb HJ, Neubauer A, Hossfeld DK, Nerl C, Gratwohl A, Baerlocher GM, Burchert A, Brümmendorf TH, Hasford J, Hochhaus A, Saußele S, Baccarani M; SAKK and the German CML Study Group. Hehlmann R, et al. Leukemia. 2020 Aug;34(8):2074-2086. doi: 10.1038/s41375-020-0826-9. Epub 2020 May 7. Leukemia. 2020. PMID: 32382082 Free PMC article.
148 results